Preview Mode Links will not work in preview mode

Jun 6, 2024

Featuring perspectives from Ms Ilene Galinsky, Dr Andrew T Kuykendall, Dr Sara M Tinsley-Vance and Dr Abdulraheem Yacoub, including the following topics:

  • Introduction (0:00)
  • The Biology of Myelofibrosis (MF) (14:00)
  • Role of Available and Investigational JAK inhibitors for the Management of MF (45:49)
  • Promising Agents...


May 29, 2024

Featuring perspectives from Dr Andrew D Zelenetz, including the following topics:

  • Follicular Lymphoma (0:00)
  • Mantle Cell Lymphoma (30:29)
  • Diffuse Large B-Cell Lymphoma (55:01)
  • Hodgkin Lymphoma (1:12:25)

CME information and select...


May 28, 2024

Featuring a slide presentation and related discussion from Dr Elias Jabbour, including the following topics:

  • Clinical management of Philadelphia chromosome-positive (Ph-positive) acute lymphoblastic leukemia (ALL); factors in the selection of initial induction  treatment (0:00)
  • Primary and secondary endpoint...


May 28, 2024

Featuring an interview with Dr Elias Jabbour, including the following topics:

  • Evolution of research and therapeutic options for acute lymphoblastic leukemia (ALL) (0:00)
  • Clinical and biological characteristics of ALL and implications for prognosis and disease management (6:36)
  • Case: A 48-year-old woman with...


May 24, 2024

Featuring a slide presentation and related discussion from Dr Joshua Richter, including the following topics:

  • Similarities and differences between the cellular targets and mechanisms of action of BCMA- and non-BCMA-directed bispecific antibodies for multiple myeloma (MM) (0:00)
  • Antitumor activity observed with...